Healthcare
Live Price
Offline$12.85
+0.00% today
1Y Change
+51.93%
Window
Jun 26, 2025 โ Jun 18, 2026
Coverage: 246 bars ยท Jun 26, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Astellas Pharma Inc. (ALPMF) is a Healthcare stock with a market cap of $3.95T. The stock last traded around $12.85 and up 51.9% across the available one-year price window (Jun 26, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +12.6%, EPS growth of +480.5%, a dividend yield of 3.5%. What stands out right now is revenue +12.6%, EPS +480.5%, free cash flow +273.0% with operating margin 18.9% and ROIC 12.1%. The dividend matters to the case here, with a current yield around 3.5%. Valuation is more restrained than many high-expectation growth names at P/E 13.6 and price/sales 1.8. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ALPMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ALPMF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ALPMF Max Drawdown
-26.14%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for ALPMF and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.